Your cart

Your cart is empty

Add a test to get started.

Browse tests

3,600+ tests. One place to find yours in Hyderabad.

Book on call+91 9135 353 535 · 7 AM–9 PM
Book on WhatsAppChat with our care team
My ordersTrack and manage bookings
MembershipSave 10% on every test

No results found

Try adjusting your filters or search term.

Test details
Test · Diagnostics

IHC - Er Pr Her2 Neu & Ki67

Free home sample collection, physician reviewedDaily , Report 5 DaysReports inBloodSample

ER & PR receptor assays are routinely performed on Breast carcinoma to assess responsiveness to endocrine therapy and prognosis. Her-2 expression predicts responsiveness to Herceptin therapy. Ki-67 in addition is a useful prognositc marker. Together ER, PR, Her-2 and Ki 67 help to predict prognosis and serve as surrogate IHC markers for molecular subtypes of Breast Cancer. Reporting through digital images using Visiopharm AI algorithms enhances the sensitivity of the assay.

₹6,000—Members pay ₹5400